David M. Parry

2.1k total citations
57 papers, 1.6k citations indexed

About

David M. Parry is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, David M. Parry has authored 57 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Organic Chemistry. Recurrent topics in David M. Parry's work include Chemical Synthesis and Analysis (6 papers), Metabolism and Genetic Disorders (5 papers) and Neonatal Health and Biochemistry (4 papers). David M. Parry is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Metabolism and Genetic Disorders (5 papers) and Neonatal Health and Biochemistry (4 papers). David M. Parry collaborates with scholars based in Canada, United Kingdom and United States. David M. Parry's co-authors include Peter L. Pedersen, William R. Pitt, Colin R. Groom, Benjamin Perry, John Krahn, Donald R. Duerksen, John T. Brosnan, Jian Dai, Stanley M. Roberts and M. Leroux and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

David M. Parry

54 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David M. Parry Canada 22 554 409 250 197 140 57 1.6k
Rajiv Sharma India 27 589 1.1× 646 1.6× 181 0.7× 99 0.5× 74 0.5× 148 2.0k
Hisashi Shinkai Japan 14 573 1.0× 291 0.7× 498 2.0× 158 0.8× 80 0.6× 27 1.6k
Duane A. Burnett United Kingdom 26 728 1.3× 1.1k 2.7× 355 1.4× 380 1.9× 107 0.8× 108 2.6k
Raymond E. Counsell United States 23 743 1.3× 354 0.9× 341 1.4× 381 1.9× 43 0.3× 163 2.4k
Daniela Rossi Italy 30 1.2k 2.2× 388 0.9× 131 0.5× 65 0.3× 125 0.9× 147 2.8k
Steven M. Pitzenberger United States 20 609 1.1× 418 1.0× 145 0.6× 64 0.3× 98 0.7× 49 1.5k
Scott J. Weir United States 29 928 1.7× 162 0.4× 175 0.7× 301 1.5× 81 0.6× 106 2.2k
Ping Zhou China 24 603 1.1× 161 0.4× 167 0.7× 226 1.1× 60 0.4× 107 1.7k
Hussein Hallak Palestinian Territory 22 565 1.0× 165 0.4× 175 0.7× 354 1.8× 59 0.4× 70 1.8k

Countries citing papers authored by David M. Parry

Since Specialization
Citations

This map shows the geographic impact of David M. Parry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Parry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Parry more than expected).

Fields of papers citing papers by David M. Parry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Parry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Parry. The network helps show where David M. Parry may publish in the future.

Co-authorship network of co-authors of David M. Parry

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Parry. A scholar is included among the top collaborators of David M. Parry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Parry. David M. Parry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Randell, Edward, et al.. (2018). Autoverification process improvement by Six Sigma approach: Clinical chemistry & immunoassay. Clinical Biochemistry. 55. 42–48. 20 indexed citations
2.
Randell, Edward, et al.. (2018). Strategy for 90% autoverification of clinical chemistry and immunoassay test results using six sigma process improvement. Data in Brief. 18. 1740–1749. 10 indexed citations
3.
Zawati, Ma’n H., David M. Parry, & Bartha Maria Knoppers. (2014). The best interests of the child and the return of results in genetic research: international comparative perspectives. BMC Medical Ethics. 15(1). 72–72. 20 indexed citations
4.
Zawati, Ma’n H., et al.. (2014). Ethics education for clinician–researchers in genetics: The combined approach. PubMed. 4. 16–20. 5 indexed citations
5.
Buckley, George M., Richard Fosbeary, Lewis Gowers, et al.. (2008). IRAK-4 inhibitors. Part III: A series of imidazo[1,2-a]pyridines. Bioorganic & Medicinal Chemistry Letters. 18(12). 3656–3660. 38 indexed citations
6.
Buckley, George M., Lewis Gowers, Alícia P. Higueruelo, et al.. (2008). IRAK-4 inhibitors. Part 1: A series of amides. Bioorganic & Medicinal Chemistry Letters. 18(11). 3211–3214. 29 indexed citations
7.
Buckley, George M., T.A. Ceska, Lewis Gowers, et al.. (2008). IRAK-4 inhibitors. Part II: A structure-based assessment of imidazo[1,2-a]pyridine binding. Bioorganic & Medicinal Chemistry Letters. 18(11). 3291–3295. 38 indexed citations
8.
Duerksen, Donald R., et al.. (2005). Intestinal Permeability in Long-Term Follow-up of Patients with Celiac Disease on a Gluten-Free Diet. Digestive Diseases and Sciences. 50(4). 785–790. 68 indexed citations
9.
Davenport, Richard, Lewis Gowers, Roland L. Knight, et al.. (2003). A novel series of potent and selective IKK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(2). 409–412. 43 indexed citations
10.
Bector, Savita, et al.. (2002). A comparison of the effect of elemental and immune‐enhancing polymeric jejunal feeding on exocrine pancreatic function. Journal of Parenteral and Enteral Nutrition. 26(3). 205–208. 7 indexed citations
11.
Ermann, Monika, et al.. (2002). Some regioselective cross-coupling reactions of halopyridines and halopyrimidines. Journal of the Chemical Society Perkin Transactions 1. 1847–1849. 19 indexed citations
12.
Duerksen, Donald R., et al.. (2000). CASE REPORT: Chronic Hyperlipasemia Causedby Sarcoidosis. Digestive Diseases and Sciences. 45(8). 1545–1548. 7 indexed citations
13.
Duerksen, Donald R., Savita Bector, Clifford S. Yaffe, & David M. Parry. (2000). Does jejunal feeding with a polymeric immune-enhancing formula increase pancreatic exocrine output as compared with TPN? A case report. Nutrition. 16(1). 47–49. 7 indexed citations
14.
Parry, David M., et al.. (1999). False positive analytical interference of cardiac troponin I assays: an important consideration for method selection. Clinical Biochemistry. 32(8). 667–669. 18 indexed citations
15.
Krahn, John, et al.. (1999). High percentage of false positive cardiac troponin I results in patients with rheumatoid factor. Clinical Biochemistry. 32(6). 477–480. 64 indexed citations
16.
Magnus, Philip, et al.. (1997). Synthetic and Mechanistic Studies on the Azabicyclo[7.3.1]enediyne Core and Naphtho[2,3-h]quinoline Portions of Dynemicin A. Journal of the American Chemical Society. 119(24). 5591–5605. 30 indexed citations
17.
Dai, Jian, John Krahn, & David M. Parry. (1996). Clinical impact of transcutaneous bilirubinometry as an adjunctive screen for hyperbilirubinemia. Clinical Biochemistry. 29(6). 581–586. 16 indexed citations
18.
Ron, Elaine, Robert E. Tarone, Baruch Modan, et al.. (1994). In vitro radiosensitivity of fibroblasts from thyroid and skin cancer patients treated with X-rays for tinea capitis.. PubMed. 3(3). 229–32. 5 indexed citations
19.
Magnus, Philip, et al.. (1994). Short synthesis of the dynemicin core structure: unusual bridgehead enolate reactivity. Journal of the Chemical Society Chemical Communications. 1543–1543. 22 indexed citations
20.
Parry, David M., et al.. (1992). Hexokinase receptors: Preferential enzyme binding in normal cells to nonmitochondrial sites and in transformed cells to mitochondrial sites. Journal of Bioenergetics and Biomembranes. 24(1). 47–53. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rajiv Sharma Breakdown of academic impact, for papers by Hisashi Shinkai Breakdown of academic impact, for papers by Duane A. Burnett Breakdown of academic impact, for papers by Raymond E. Counsell Breakdown of academic impact, for papers by Daniela Rossi Breakdown of academic impact, for papers by Steven M. Pitzenberger Breakdown of academic impact, for papers by Scott J. Weir Breakdown of academic impact, for papers by Ping Zhou Breakdown of academic impact, for papers by Hussein Hallak
Rankless by CCL
2026